|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,055,585 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$64,994,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 20 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Director |
|
2017-04-07 |
4 |
AB |
$139.48 |
$139,480 |
D/D |
1,000 |
2,177 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-04-13 |
4 |
AB |
$139.66 |
$139,660 |
D/D |
1,000 |
3,177 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-04-25 |
4 |
AS |
$94.00 |
$470,000 |
D/D |
(5,000) |
238,194 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-04-25 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
243,194 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-04-27 |
4 |
AS |
$95.72 |
$478,600 |
D/D |
(5,000) |
238,194 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-04-27 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
243,194 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-04-28 |
4 |
A |
$70.30 |
$21,232 |
D/D |
302 |
238,496 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-04-28 |
4 |
AB |
$124.26 |
$62,130 |
D/D |
500 |
3,677 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-05 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
243,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-05 |
4 |
AS |
$99.00 |
$495,000 |
D/D |
(5,000) |
238,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-08 |
4 |
AS |
$93.17 |
$465,850 |
D/D |
(5,000) |
238,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-08 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
243,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-12 |
4 |
AS |
$89.23 |
$446,150 |
D/D |
(5,000) |
238,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-12 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
243,496 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-05-15 |
4 |
AB |
$115.00 |
$57,500 |
D/D |
500 |
4,177 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-15 |
4 |
D |
$91.50 |
$451,278 |
D/D |
(4,932) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-17 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
238,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-17 |
4 |
AS |
$91.73 |
$458,650 |
D/D |
(5,000) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-24 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
238,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-24 |
4 |
AS |
$88.38 |
$441,900 |
D/D |
(5,000) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-31 |
4 |
OE |
$17.33 |
$128,641 |
D/D |
7,423 |
240,987 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-31 |
4 |
AS |
$88.29 |
$655,377 |
D/D |
(7,423) |
233,564 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-05-31 |
4 |
AB |
$131.80 |
$65,900 |
D/D |
500 |
4,677 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-01 |
4 |
AS |
$87.53 |
$437,650 |
D/D |
(5,000) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-01 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
238,564 |
0 |
- |
|
852 Records found
|
|
Page 20 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|